{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:41:06Z","timestamp":1792669266120,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.jviromet.2009.09.016","type":"journal-article","created":{"date-parts":[[2009,9,23]],"date-time":"2009-09-23T14:50:58Z","timestamp":1253717458000},"page":"195-204","source":"Crossref","is-referenced-by-count":32,"title":["The combination of marker gene swapping and fluorescence-activated cell sorting improves the efficiency of recombinant modified vaccinia virus Ankara vaccine production for human use"],"prefix":"10.1016","volume":"163","author":[{"given":"Giulia","family":"Di Lullo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Soprana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Panigada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Palini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Agresti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Comunian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelaide","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Capua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Erfle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio G.","family":"Siccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2009.09.016_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0959-437X(03)00023-6","article-title":"HMGB proteins and gene expression","volume":"13","author":"Agresti","year":"2003","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.jviromet.2009.09.016_bib2","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0264-410X(02)00076-2","article-title":"Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA\/MVA vaccine","volume":"20","author":"Amara","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2009.09.016_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1998.9123","article-title":"The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses","volume":"244","author":"Antoine","year":"1998","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2009.09.016_bib4","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1128\/JVI.75.11.5151-5158.2001","article-title":"Reduction of simian-human immunodeficiency virus 89.6P viremia in rhesus monkeys by recombinant modified vaccinia virus Ankara vaccination","volume":"75","author":"Barouch","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2009.09.016_bib5","doi-asserted-by":"crossref","first-page":"e707","DOI":"10.1371\/journal.pone.0000707","article-title":"Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya","volume":"2","author":"Bejon","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jviromet.2009.09.016_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.1997.8845","article-title":"Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line","volume":"238","author":"Carroll","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2009.09.016_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0264-410X(96)00195-8","article-title":"Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model","volume":"15","author":"Carroll","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2009.09.016_bib8","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2144\/97236st07","article-title":"Compact, synthetic, vaccinia virus early\/late promoter for protein expression","volume":"23","author":"Chakrabarti","year":"1997","journal-title":"Biotechniques"},{"key":"10.1016\/j.jviromet.2009.09.016_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0264-410X(03)00538-3","article-title":"Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals","volume":"22","author":"Cosma","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2009.09.016_bib10","doi-asserted-by":"crossref","first-page":"e1638","DOI":"10.1371\/journal.pone.0001638","article-title":"Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA)","volume":"3","author":"Cottingham","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jviromet.2009.09.016_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jviromet.2008.10.026","article-title":"Marker gene swapping facilitates recombinant modified vaccinia virus Ankara production by host-range selection","volume":"156","author":"Di Lullo","year":"2009","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.jviromet.2009.09.016_bib12","first-page":"4955","article-title":"Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo","volume":"59","author":"Drexler","year":"1999","journal-title":"Cancer Res."},{"issue":"Pt 2","key":"10.1016\/j.jviromet.2009.09.016_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1099\/0022-1317-79-2-347","article-title":"Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells","volume":"79","author":"Drexler","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2009.09.016_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10616-005-3795-y","article-title":"Current status for high titre poxvirus stock preparation in CEF under serum-free medium conditions: implication for vaccine development","volume":"48","author":"Gilbert","year":"2005","journal-title":"Cytotechnology"},{"key":"10.1016\/j.jviromet.2009.09.016_bib15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1128\/JVI.39.3.903-913.1981","article-title":"Characterization of intracellular and extracellular vaccinia virus variants: N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine interferes with cytoplasmic virus dissemination and release","volume":"39","author":"Hiller","year":"1981","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2009.09.016_bib16","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1128\/JVI.70.6.3741-3752.1996","article-title":"Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara","volume":"70","author":"Hirsch","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2009.09.016_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1083\/jcb.200104124","article-title":"Vaccinia virus utilizes microtubules for movement to the cell surface","volume":"154","author":"Hollinshead","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jviromet.2009.09.016_bib18","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1016\/j.vaccine.2008.02.071","article-title":"Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa","volume":"26","author":"Jaoko","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2009.09.016_bib19","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1084\/jem.129.4.795","article-title":"Inhibition of release of vaccinia virus by N1-isonicotinoly-N2-3-methyl-4-chlorobenzoylhydrazine","volume":"129","author":"Kato","year":"1969","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jviromet.2009.09.016_bib20","first-page":"251","article-title":"Significance of animal pox for man following elimination of compulsory vaccination against smallpox","volume":"92","author":"Mayr","year":"1979","journal-title":"Berl. Munch. Tierarztl. Wochenschr."},{"key":"10.1016\/j.jviromet.2009.09.016_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01641272","article-title":"Abstammung Eigenschaften und Verwendung des attenuierten Vaccinia-Stammes MVA","volume":"3","author":"Mayr","year":"1975","journal-title":"Infection"},{"key":"10.1016\/j.jviromet.2009.09.016_bib22","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nm881","article-title":"Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans","volume":"9","author":"McConkey","year":"2003","journal-title":"Nat. Med."},{"issue":"Pt 5","key":"10.1016\/j.jviromet.2009.09.016_bib23","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1099\/0022-1317-72-5-1031","article-title":"Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence","volume":"72","author":"Meyer","year":"1991","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2009.09.016_bib24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF01320778","article-title":"The effect of cytochalasin D and monensin on enveloped vaccinia virus release","volume":"74","author":"Payne","year":"1982","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jviromet.2009.09.016_bib25","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1128\/JVI.74.16.7651-7655.2000","article-title":"Attenuated modified vaccinia virus Ankara can be used as an immunizing agent under conditions of preexisting immunity to the vector","volume":"74","author":"Ramirez","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2009.09.016_bib26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nm0498-397","article-title":"Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara","volume":"4","author":"Schneider","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.jviromet.2009.09.016_bib27","doi-asserted-by":"crossref","DOI":"10.2144\/00286st04","article-title":"Transient host range selection for genetic engineering of modified vaccinia virus Ankara","volume":"28","author":"Staib","year":"2000","journal-title":"Biotechniques"},{"key":"10.1016\/j.jviromet.2009.09.016_bib28","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jviromet.2009.09.016_bib29","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1128\/JVI.68.7.4109-4116.1994","article-title":"Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant","volume":"68","author":"Sutter","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2009.09.016_bib30","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1084\/jem.20081165","article-title":"Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE","volume":"205","author":"Urbonaviciute","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jviromet.2009.09.016_bib31","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1016\/S0264-410X(00)00531-4","article-title":"Vaccination with recombinant modified vaccinia virus Ankara protects against measles virus infection in the mouse and cotton rat model","volume":"19","author":"Weidinger","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2009.09.016_bib32","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0264-410X(96)00072-2","article-title":"Development of a replication-deficient recombinant vaccinia virus vaccine effective against parainfluenza virus 3 infection in an animal model","volume":"14","author":"Wyatt","year":"1996","journal-title":"Vaccine"}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093409004169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093409004169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T11:35:01Z","timestamp":1590147301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093409004169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0166093409004169"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2009.09.016","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}